
    
      Study Population:

      Patients with histologically or cytologically confirmed recurrent or metastatic squamous cell
      carcinoma of oral cavity, oropharynx, paranasal sinuses, hypopharynx, or larynx that is not
      amenable to local therapy with curative intent. Squamous cell carcinoma of unknown primary in
      cervical lymph node can be included only if p16 status is positive.
    
  